These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17457646)

  • 21. Vancomycin-intermediate Staphylococcus aureus with phenotypic susceptibility to methicillin in a patient with recurrent bacteremia.
    Naimi TS; Anderson D; O'Boyle C; Boxrud DJ; Johnson SK; Tenover FC; Lynfield R
    Clin Infect Dis; 2003 Jun; 36(12):1609-12. PubMed ID: 12802763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin.
    Jo A; Ahn J
    BMC Microbiol; 2016 Jul; 16(1):170. PubMed ID: 27473500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of low-level oxacillin resistance in mecA-positive Staphylococcus aureus.
    Witte W; Pasemann B; Cuny C
    Clin Microbiol Infect; 2007 Apr; 13(4):408-12. PubMed ID: 17359325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High level oxacillin and vancomycin resistance and altered cell wall composition in Staphylococcus aureus carrying the staphylococcal mecA and the enterococcal vanA gene complex.
    Severin A; Tabei K; Tenover F; Chung M; Clarke N; Tomasz A
    J Biol Chem; 2004 Jan; 279(5):3398-407. PubMed ID: 14613936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA.
    Werth BJ; Vidaillac C; Murray KP; Newton KL; Sakoulas G; Nonejuie P; Pogliano J; Rybak MJ
    Antimicrob Agents Chemother; 2013 May; 57(5):2376-9. PubMed ID: 23422917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.
    Hsueh PR; Lee SY; Perng CL; Chang TY; Lu JJ
    Int J Antimicrob Agents; 2010 Oct; 36(4):307-12. PubMed ID: 20685086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the regulating gene of femA from methicillin-resistant Staphylococcus aureus clinical isolates.
    Li X; Xiong Y; Fan X; Zhong Z; Feng P; Tang H; Zhou T
    J Int Med Res; 2008; 36(3):420-33. PubMed ID: 18534123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs.
    Swenson JM; Lonsway D; McAllister S; Thompson A; Jevitt L; Zhu W; Patel JB
    Diagn Microbiol Infect Dis; 2007 May; 58(1):33-9. PubMed ID: 17240109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of sigB mutation on Staphylococcus aureus oxacillin and vancomycin resistance varies with parental background and method of assessment.
    Singh VK; Schmidt JL; Jayaswal RK; Wilkinson BJ
    Int J Antimicrob Agents; 2003 Mar; 21(3):256-61. PubMed ID: 12636988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the performance of the MicroScan Pos Breakpoint Combo Panel Type 28 for susceptibility testing of Staphylococcus aureus: low-range minimum inhibitory concentration of vancomycin, cefoxitin screening, and inducible clindamycin resistance detection].
    Ji M; Lee M; Noh S; Kim MN
    Korean J Lab Med; 2010 Dec; 30(6):637-46. PubMed ID: 21157151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detection of non-multidrug-resistant and multidrug-resistant methicillin-resistant Staphylococcus aureus using cycling probe technology for the mecA gene.
    Merlino J; Rose B; Harbour C
    Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):322-3. PubMed ID: 12736792
    [No Abstract]   [Full Text] [Related]  

  • 33. Glycopeptide and oxacillin activity against Staphylococcus aureus isolates at a tertiary care center in Lebanon.
    Kanj SS; Ghaleb PA; Araj GF
    J Med Liban; 2004; 52(1):8-12. PubMed ID: 15881695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.
    Bhateja P; Purnapatre K; Dube S; Fatma T; Rattan A
    Int J Antimicrob Agents; 2006 Mar; 27(3):201-11. PubMed ID: 16417988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and sequencing of the gene, fmtC, which affects oxacillin resistance in methicillin-resistant Staphylococcus aureus.
    Komatsuzawa H; Ohta K; Fujiwara T; Choi GH; Labischinski H; Sugai M
    FEMS Microbiol Lett; 2001 Sep; 203(1):49-54. PubMed ID: 11557139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population structure and characterisation of Staphylococcus aureus from bacteraemia at multiple hospitals in China: association between antimicrobial resistance, toxin genes and genotypes.
    He W; Chen H; Zhao C; Zhang F; Li H; Wang Q; Wang X; Wang H
    Int J Antimicrob Agents; 2013 Sep; 42(3):211-9. PubMed ID: 23871455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxacillin sensitization of methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus pseudintermedius by antisense peptide nucleic acids in vitro.
    Goh S; Loeffler A; Lloyd DH; Nair SP; Good L
    BMC Microbiol; 2015 Nov; 15():262. PubMed ID: 26560174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First Report on Vancomycin-Resistant Staphylococcus aureus in Bovine and Caprine Milk.
    Bhattacharyya D; Banerjee J; Bandyopadhyay S; Mondal B; Nanda PK; Samanta I; Mahanti A; Das AK; Das G; Dandapat P; Bandyopadhyay S
    Microb Drug Resist; 2016 Dec; 22(8):675-681. PubMed ID: 26990514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell wall deficiency and its effect on methicillin heteroresistance in Staphylococcus aureus.
    Markova N; Haydoushka I; Michailova L; Ivanova R; Valcheva V; Jourdanova M; Popova T; Radoucheva T
    Int J Antimicrob Agents; 2008 Mar; 31(3):255-60. PubMed ID: 18155449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiological and clinical study of methicillin-resistant Staphylococcus aureus (MRSA) carrying VraS mutation: changes in susceptibility to glycopeptides and clinical significance.
    Kato Y; Suzuki T; Ida T; Maebashi K; Sakurai M; Shiotani J; Hayashi I
    Int J Antimicrob Agents; 2008 Jan; 31(1):64-70. PubMed ID: 18029148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.